These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11940313)

  • 41. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life.
    Kearney DJ; McDermott K; Martinez M; Simpson TL
    Aliment Pharmacol Ther; 2011 Aug; 34(3):363-73. PubMed ID: 21651595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.
    Badia X; Mearin F; Balboa A; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Pharmacoeconomics; 2002; 20(11):749-58. PubMed ID: 12201794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The short-term natural history of irritable bowel syndrome: a time-series analysis.
    Stevens JA; Wan CK; Blanchard EB
    Behav Res Ther; 1997 Apr; 35(4):319-26. PubMed ID: 9134786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial.
    Ljótsson B; Hedman E; Andersson E; Hesser H; Lindfors P; Hursti T; Rydh S; Rück C; Lindefors N; Andersson G
    Am J Gastroenterol; 2011 Aug; 106(8):1481-91. PubMed ID: 21537360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteopathy improves the severity of irritable bowel syndrome: a pilot randomized sham-controlled study.
    Florance BM; Frin G; Dainese R; Nébot-Vivinus MH; Marine Barjoan E; Marjoux S; Laurens JP; Payrouse JL; Hébuterne X; Piche T
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):944-9. PubMed ID: 22546751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms.
    Hebden JM; Blackshaw E; D'Amato M; Perkins AC; Spiller RC
    Am J Gastroenterol; 2002 Sep; 97(9):2315-20. PubMed ID: 12358250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An epidemiological and quality of life study of irritable bowel syndrome in Zhejiang province].
    Si JM; Chen SJ; Sun LM
    Zhonghua Nei Ke Za Zhi; 2003 Jan; 42(1):34-7. PubMed ID: 12757662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.
    Dehkordi AH; Solati K
    J Adv Pharm Technol Res; 2017; 8(2):67-72. PubMed ID: 28516059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome.
    Riedl A; Maass J; Fliege H; Stengel A; Schmidtmann M; Klapp BF; Mönnikes H
    J Psychosom Res; 2009 Nov; 67(5):449-55. PubMed ID: 19837208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.
    Moss-Morris R; McAlpine L; Didsbury LP; Spence MJ
    Psychol Med; 2010 Jan; 40(1):85-94. PubMed ID: 19531276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
    Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Irritable bowel syndrome: update on pathogenesis and management.
    Alaradi O; Barkin JS
    Med Princ Pract; 2002; 11(1):2-17. PubMed ID: 12116690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of irritable bowel syndrome in caregivers of patients with chronic diseases.
    Remes-Troche JM; Torres-Aguilera M; Montes-Martínez V; Jiménez-García VA; Roesch-Dietlen F
    Neurogastroenterol Motil; 2015 Jun; 27(6):824-31. PubMed ID: 25817438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive-behavioral group therapy for patients with irritable bowel syndrome.
    Toner BB; Segal ZV; Emmott S; Myran D; Ali A; DiGasbarro I; Stuckless N
    Int J Group Psychother; 1998 Apr; 48(2):215-43. PubMed ID: 9563239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.
    Lackner JM; Jaccard J; Radziwon CD; Firth RS; Gudleski GD; Hamilton F; Katz LA; Keefer L; Krasner SS; Ma CX; Sitrin MD; Brenner DM
    Am J Gastroenterol; 2019 Feb; 114(2):330-338. PubMed ID: 30429592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The irritable bowel syndrome.
    Hasler WL
    Med Clin North Am; 2002 Nov; 86(6):1525-51. PubMed ID: 12510463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychological changes associated with self-regulatory treatments of irritable bowel syndrome.
    Blanchard EB; Radnitz C; Schwarz SP; Neff DF; Gerardi MA
    Biofeedback Self Regul; 1987 Mar; 12(1):31-7. PubMed ID: 3663736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of life in irritable bowel syndrome, effect of therapy.
    Chassany O; Bergmann JF
    Eur J Surg Suppl; 1998; (583):81-6. PubMed ID: 10027679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The treatment of irritable bowel syndrome with hypnotherapy.
    Galovski TE; Blanchard EB
    Appl Psychophysiol Biofeedback; 1998 Dec; 23(4):219-32. PubMed ID: 10457813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral treatment of irritable bowel syndrome: a 1-year follow-up study.
    Schwarz SP; Blanchard EB; Neff DF
    Biofeedback Self Regul; 1986 Sep; 11(3):189-98. PubMed ID: 3300787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.